BioSpace News Archive

Caris Life Sciences®, the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition, announced that UC Davis Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™.

I-Mab announced its financial results for the six months ended June 30, 2023, and provided key business updates.

Tiziana Life Sciences Ltd. today announced that Dr. Howard L. Weiner, a thought leader in the field of neurology and immunology, was featured in an exclusive live interview on Bloomberg to discuss the Company’s latest announcement on its advancement of the novel foralumab program in Alzheimer’s disease following recent U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) clearance.

Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies for autoimmune diseases and gene therapies, today reported financial results for the second quarter ended June 30, 2023 and provided a business update.

Foresight Diagnostics, a leading provider of ultrasensitive cancer detection tests, today announced the appointment of John Truesdell as Chief Business Officer.

Element Biosciences, Inc. today unveiled five new products to better serve customers’ low to medium-throughput needs and expand the functionality and versatility of its benchtop sequencer.

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today provided first half, 2023, financial results and operational highlights.

Johnson & Johnson’s subsidiary Janssen made headlines again in August 2023 when the FDA approved its product talquetamab under the agency’s accelerated approval program.

Altruix announced today that it has been selected as a limited distribution partner by Braeburn Inc. for BRIXADI (buprenorphine) extended-release subcutaneous injection (CIII).

Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple disciplines and functions, has been appointed Chief Sustainability Officer effective immediately.